<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-17T20:33:02Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:20.500.12327/1761" metadataPrefix="marc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:20.500.12327/1761</identifier><datestamp>2025-10-22T11:25:11Z</datestamp><setSpec>com_2072_4428</setSpec><setSpec>com_2072_4427</setSpec><setSpec>col_2072_487898</setSpec></header><metadata><record xmlns="http://www.loc.gov/MARC21/slim" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.loc.gov/MARC21/slim http://www.loc.gov/standards/marcxml/schema/MARC21slim.xsd">
   <leader>00925njm 22002777a 4500</leader>
   <datafield ind2=" " ind1=" " tag="042">
      <subfield code="a">dc</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">López-Cano, Adrià</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Bach, Alex</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">López-Serrano, Sergi</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Aragon, Virginia</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Blanch, Marta</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Pastor, Jose J.</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Tedó, Gemma</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Morais, Sofia</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Garcia-Fruitos, Elena</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="720">
      <subfield code="a">Alomar, Oscar</subfield>
      <subfield code="e">author</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="260">
      <subfield code="c">2022-04-21</subfield>
   </datafield>
   <datafield ind2=" " ind1=" " tag="520">
      <subfield code="a">Antimicrobial resistance is a global threat that is worryingly rising in the livestock sector.&#xd;
Among the proposed strategies, immunostimulant development appears an interesting approach to&#xd;
increase animal resilience at critical production points. The use of nanoparticles based on cytokine&#xd;
aggregates, called inclusion bodies (IBs), has been demonstrated as a new source of immunostimulants&#xd;
in aquaculture. Aiming to go a step further, the objective of this study was to produce cytokine&#xd;
nanoparticles using a food-grade microorganism and to test their applicability to stimulate intestinal&#xd;
mucosa in swine. Four cytokines (IL-1β, IL-6, IL-8, and TNF-α) involved in inflammatory response&#xd;
were produced recombinantly in Lactococcus lactis in the form of protein nanoparticles (IBs). They&#xd;
were able to stimulate inflammatory responses in a porcine enterocyte cell line (IPEC-J2) and alveolar&#xd;
macrophages, maintaining high stability at low pH and high temperature. In addition, an in vivo&#xd;
assay was conducted involving 20 piglets housed individually as a preliminary exploration of the&#xd;
potential effects of IL-1β nanoparticles in piglet intestinal mucosa after a 7 d oral administration. The&#xd;
treated animals tended to have greater levels of TNF-α in the blood, indicating that the tested dose of&#xd;
nanoparticles tended to generate an inflammatory response in the animals. Whether this response is&#xd;
sufficient to increase animal resilience needs further evaluation.</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">López-Cano, Adrià, Alex Bach, Sergi López-Serrano, Virginia Aragon, Marta Blanch, Jose J. Pastor, Gemma Tedó, Sofia Morais, Elena Garcia-Fruitós, and Anna Arís. 2022. "Potential Of Oral Nanoparticles Containing Cytokines As Intestinal Mucosal Immunostimulants In Pigs: A Pilot Study". Animals 12 (9): 1075. doi:10.3390/ani12091075.</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">2076-2615</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">http://hdl.handle.net/20.500.12327/1761</subfield>
   </datafield>
   <datafield ind1="8" ind2=" " tag="024">
      <subfield code="a">https://doi.org/10.3390/ani12091075</subfield>
   </datafield>
   <datafield ind2="0" ind1="0" tag="245">
      <subfield code="a">Potential of Oral Nanoparticles Containing Cytokines as Intestinal Mucosal Immunostimulants in Pigs: A Pilot Study</subfield>
   </datafield>
</record></metadata></record></GetRecord></OAI-PMH>